Anterior segment optical coherence tomography angiography in the assessment of ocular surface lesions
Introduction
Benign or malignant conjunctival tumors, or ocular surface lesions, are generally classified as melanocytic and non-melanocytic [1]. The latter can be further sub-categorized into epithelial, lymphoid, vascular, lipomatous, fibrous, myogenic, histiocytic, neural, metastatic and secondary tumors [[1], [2], [3]]. These lesions are generally diagnosed through their clinical features, history, risk factors, evolution, location, and confirmed through histopathology [1,4,5]. Morphological lesion characteristics on slit-lamp examination, such as anatomical location, basal diameter, pigmentation, presence of cysts or feeder vessels, have been used to distinguish benign from malignant tumors [6].
The benefits of complimentary diagnostic imaging have been demonstrated for the assessment of these lesions. Ultrasound bio-microscopy, for example, is commonly used to determine the intraocular tumor invasion depth and metastasis, showing limited image resolution with good tissue penetration for the anterior segment [[7], [8], [9]]. Its main disadvantages are the axial resolution, limited accessibility to this imaging technique, the need for submersion and contact under topical anesthesia, and experienced operator for image acquisition [10,11]. The study of the vasculature pattern in ocular tumors may provide additional insight into diagnosis and prognosis of tumors [12]. Although this concept is well established in chorioretinal tumors, studies on anterior segment tumors are scarce [13]. Brunner et al. have recently described the vascular characteristics of ocular surface neoplasia as assessed by indocyanine green angiography (ICGA) [14]. They analyzed epithelial and pigmented lesions, and provided measurements, such as mean vessel diameter, lesion filling times, and quantification of afferent and efferent vessels, with a significantly decreased lesion filling time in malignant lesions, compared to benign lesions.
Anterior segment-optical coherence tomography (AS-OCT) is a non-invasive and non-contact device that can generate high-resolution cross-sectional B-scans of the ocular surface, using near-infrared light with an approximately 5 μm axial resolution [15]. In ocular surface squamous neoplasia (OSSN), it has previously been used to assess the lesion thickness and epithelial thickness [11,16]. The limitation of AS-OCT, however, is the inability to provide functional parameters, such as blood flow. Furthermore, the novel AS-OCT angiography (AS-OCTA) is capable of detecting blood vessel flow (by calculating decorrelation signals) from the red blood cell movement within the vessels through sequential en face scans at the same location. This modality is now widely used in retinal vascular diseases [17] and recently for intraocular tumors [18,19]. The main disadvantages of OCTA, unlike other angiography techniques with dye injection, are the inability to accurately determine venous from arterial and to detect vessel leakage.
The application of AS-OCTA has shown promising results in corneal neovascularization and other ocular surface diseases [20,21]. However, the utility of AS-OCTA in ocular surface tumors remains underexplored. We hypothesize that this novel feature can provide qualitative and quantitative vascular parameters that can aid in the assessment of ocular surface lesions. The aim of this study is to investigate vascular depth and diameter as assessed by AS-OCTA in ocular surface lesions, and to explore if these parameters demonstrate significant differences between malignant and benign lesions. Herein, we describe the preliminary utility of this technology in the setting of ocular surface tumors.
Section snippets
Patient selection
The OCT database and clinical records of patients with conjunctival lesions in which AS-OCTA imaging was performed for clinical purposes at the Cornea Service, New England Eye Center, Department of Ophthalmology, Tufts Medical Center, Boston, Massachusetts, were reviewed between November 2016 and December 2019. Inclusion criteria were patients with diagnosis of ocular surface lesions on clinical records with AS-OCTA scans of the lesion. In order to explore the utility of AS-OCTA imaging in
Demographics
In the benign group a total of 23 eyes (22 patients) were included and in the malignant a total of 10 eyes (9 patients). All lesions in the malignant group were biopsy proven. There was no significant difference between the groups regarding the mean age (49.5 ± 22.4 and 64.3 ± 10.6 years, respectively; p = 0.145) and the gender distribution with 45.0% and 55.0% males in the respective groups (p = 0.458). The demographic data of the benign and malignant groups is displayed in Table 1 and lesion
Discussion
Herein, we report that the peri-lesional vessel depth and diameter of ocular surface lesions can be assessed objectively with AS-OCTA, with high repeatability. A significant increase of peri-lesional vessel depth and diameter was shown in malignant lesions and could be potential parameters to help distinguish them from benign lesions of the ocular surface. Our results herein highlight a high sensitivity and specificity (with high AUC) of this novel technology, adapted for the anterior segment,
Funding
Massachusetts Lions Eye Research Fund, Inc. (PH), Research to Prevent Blindness Challenge Grant to the Department of Ophthalmology, Tufts Medical Center Institutional Support (PH). The funding organizations had no role in the design or conduct of this research.
Declaration of competing interest
WWB, HM, RMN, HKW: no disclosures; JSD: Carl Zeiss Meditec, Inc. (Dublin, CA, USA) (S), Optovue, Inc. (Fremont, CA, USA) (S), PH: Heidelberg Engineering (Heidelberg, Germany) (C, S).
Acknowledgements
The authors would like to acknowledge Drs Michael Raizman, Michael Goldstein and Kenneth Kenyon for their contributions with their patients' clinical charts.
References (36)
- et al.
Tumors of the conjunctiva and cornea
Surv Ophthalmol
(2004) - et al.
Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors
Ophthalmology
(2004) - et al.
The epidemiology of ophthalmic malignancies in New York State
Ophthalmology
(1990) - et al.
Conjunctival tumors in 5002 cases. Comparative analysis of benign versus malignant counterparts. The 2016 james D. Allen lecture
Am J Ophthalmol
(2017) - et al.
Assessment of anterior segment tumors with ultrasound biomicroscopy versus anterior segment optical coherence tomography in 200 cases
Ophthalmology
(2011) - et al.
Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update
Ophthalmology
(2003) - et al.
High-resolution optical coherence tomography as an adjunctive tool in the diagnosis of corneal and conjunctival pathology
Ocul Surf
(2015) - et al.
The application of optical coherence tomography angiography in retinal diseases
Surv Ophthalmol
(2017) - et al.
Optical coherence tomography angiography for anterior segment vasculature imaging
Ophthalmology
(2015) - et al.
Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study
Ophthalmology
(1991)
Survey of complications of indocyanine green angiography in Japan
Am J Ophthalmol
Impact of binarization thresholding and brightness/contrast adjustment methodology on optical coherence tomography angiography image quantification
Am J Ophthalmol
Anterior segment optical coherence tomography of conjunctival nevus
Ophthalmology
The 1998 Pan American Lecture. Intraocular invasion of conjunctival squamous cell carcinoma in five patients
Ophthalmic Plast Reconstr Surg
Clinical presentation of ocular surface squamous neoplasia in Kenya
JAMA Ophthalmol
20 MHz high frequency ultrasound assessment of scleral and intraocular conjunctival squamous cell carcinoma
Br J Ophthalmol
Ultrasound biomicroscopy: role in diagnosis and management in 130 consecutive patients evaluated for anterior segment tumours
Br J Ophthalmol
Spectral-domain optical coherence tomography versus ultrasound biomicroscopy for imaging of nonpigmented iris tumors
Am J Ophthalmol
Cited by (8)
Recent advances in optical coherence tomography for anterior segment imaging in small animals and their clinical implications
2022, Ocular SurfaceCitation Excerpt :Similarly, through the study of higher order aberrations, it has allowed us to evaluate disease severity and optical function in ocular graft vs host disease [129]. AS-OCTA has also been successfully employed in vivo to provide novel and non-invasive functional vascular parameters that allow distinguishing malignant from benign ocular surface lesions reliably using markers such as vessel size and depth [130]. This review focuses on the OCT sub-categories of ultrahigh-resolution, spectroscopic, MM, PS, and OCTA.
The use of high resolution optical coherence tomography (HR-OCT) in the diagnosis of ocular surface masqueraders
2022, Ocular SurfaceCitation Excerpt :In many cases, HR-CT images can guide the biopsy location ensuring a good specimen is sent for analysis, especially if there is a suspicion of a false negative biopsy. More recently, OCTA has emerged as a new tool allowing for characterization and quantification of vascular networks of benign and malignant ocular surface lesions [34,35]. Hopefully, in the future HR-OCT along with OCTA will assist the physician in further evaluating ocular surface lesions.
Current clinical applications of anterior segment optical coherence tomography angiography: a review
2023, Graefe's Archive for Clinical and Experimental OphthalmologyAutomated Image Threshold Method Comparison for Conjunctival Vessel Quantification on Optical Coherenc Tomography Angiography
2022, Translational Vision Science and TechnologyAdvances in OCT Imaging in Myopia and Pathologic Myopia
2022, Diagnostics